Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 1.000 | None | 0.983 | 1637 | 35 | 1986 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.800 | strong | 0.950 | 535 | 32 | 1994 | 2020 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
disease | 0.700 | None | 0.969 | 321 | 10 | 1987 | 2020 | ||||||||
|
mitogen-activated protein kinase kinase 7 | 0.419 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0.996 | 247 | 1 | 2004 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.700 | None | 0.943 | 209 | 13 | 1991 | 2020 | ||||||||
|
melanocortin 1 receptor | 0.524 | 0.808 | 8.1E-11 |
|
disease | 0.500 | None | 0.959 | 194 | 15 | 1996 | 2020 | ||||||||
|
melanocyte inducing transcription factor | 0.499 | 0.808 | 0.98 |
|
disease | 0.700 | None | 0.974 | 194 | 7 | 2002 | 2020 | ||||||||
|
tyrosinase | 0.473 | 0.808 | 5.0E-32 |
|
disease | 0.500 | None | 0.984 | 191 | 4 | 1988 | 2019 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.500 | None | 0.967 | 183 | 23 | 1992 | 2020 | ||||||||
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
disease | 0.100 | None | 0.971 | 171 | 0 | 2008 | 2020 | ||||||||
|
interleukin 24 | 0.498 | 0.769 | 5.9E-07 |
|
disease | 0.100 | None | 1.000 | 140 | 0 | 1995 | 2019 | ||||||||
|
cyclin dependent kinase 4 | 0.412 | 0.808 | 6.3E-02 |
|
disease | 0.700 | strong | 0.961 | 128 | 3 | 1994 | 2020 | ||||||||
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
disease | 0.400 | None | 1.000 | 120 | 0 | 1990 | 2019 | ||||||||
|
melan-A | 0.579 | 0.692 | 1.3E-09 |
|
disease | 0.400 | None | 0.982 | 113 | 0 | 1994 | 2020 | ||||||||
|
cytotoxic T-lymphocyte associated protein 4 | 0.369 | 0.923 | 0.94 |
|
disease | 0.400 | None | 0.946 | 112 | 0 | 2008 | 2020 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.800 | strong | 0.950 | 101 | 4 | 1997 | 2020 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.100 | None | 0.943 | 88 | 1 | 1996 | 2020 | ||||||||
|
retrotransposon Gag like 1 | 0.554 | 0.808 | 5.6E-03 |
|
disease | 0.100 | None | 0.976 | 85 | 0 | 1995 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.500 | None | 0.965 | 85 | 2 | 2005 | 2019 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.500 | None | 0.976 | 84 | 3 | 2002 | 2020 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.100 | None | 0.976 | 84 | 0 | 1991 | 2020 | ||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
disease | 0.100 | None | 0.912 | 80 | 0 | 1994 | 2019 | |||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 80 | 0 | 2000 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
disease | 0.100 | None | 0.962 | 79 | 0 | 2005 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.961 | 77 | 0 | 2005 | 2019 |